Nab-paclitaxel

paclitaxel protein-bound

Drug timelines are a Plus or Pro feature.

327 regulatory and trial events tracked for Nab-paclitaxel, covering 2011-05-26 to 2026-07-07. Get the full timeline:

Most recent: Clinical Trial Results: Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations [Phase 2]

See pricing